Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06986603) titled 'Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia' on May 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Single (Participant).
Primary Sponsor: Joslin Diabetes Center
Condition:
Hypoglycemia
Hypoglycemia, Reactive
Bariatric Surgery
Intervention:
Drug: Glucagon for Injection (Fresenius Kabi USA)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: November 26, 2024
Target Sample Size: 28
Countries of Recruitment:
United States
To know more, visit https://clinicaltrial...